Related Experiment Video
Updated: Oct 1, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes and COVID-19; A Bidirectional Interplay
Paraskevi Kazakou1, Vaia Lambadiari2, Ignatios Ikonomidis3
1Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Insights
Diabetes mellitus (DM) increases COVID-19 severity and complications. SARS-CoV-2 infection may also cause new-onset diabetes and impair glucose homeostasis, highlighting a complex relationship requiring further study.
Area of Science:
- Endocrinology
- Infectious Diseases
- Metabolism
Background:
- Diabetes mellitus (DM) patients face higher risks for critical COVID-19 and related complications.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to metabolic dysregulation and impaired glucose homeostasis.
- Emerging evidence suggests SARS-CoV-2 may directly impact glucose metabolism, potentially causing new-onset DM.
Purpose of the Study:
- To review the pathophysiological mechanisms linking COVID-19 and glucose dysregulation.
- To explore the effects of antidiabetic treatments in diabetic patients with COVID-19.
- To understand the bidirectional interplay between DM and COVID-19 for improved patient management.
Main Methods:
- Literature review of existing clinical data and research.
- Analysis of pathophysiological pathways involving ACE2 receptors in the pancreas and endothelium.
- Examination of emerging data on new-onset DM post-SARS-CoV-2 infection.
Main Results:
- Diabetes is a significant risk factor for severe COVID-19 outcomes.
- SARS-CoV-2 infection is associated with metabolic dysregulation and hyperglycemia.
- The virus may directly affect pancreatic function and glucose metabolism via ACE2 receptors.
Conclusions:
- The relationship between COVID-19 and diabetes is bidirectional and complex.
- Understanding these interactions is crucial for managing COVID-19 complications in diabetic patients.
- Further research is needed to elucidate the direct effects of SARS-CoV-2 on glucose homeostasis and inform treatment strategies.
Abstract:
There seems to be a bidirectional interplay between Diabetes mellitus (DM) and coronavirus disease 2019 (COVID-19). On the one hand, people with diabetes are at higher risk of fatal or critical care unit-treated COVID-19 as well as COVID-19 related health complications compared to individuals without diabetes. On the other hand, clinical data so far suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may result in metabolic dysregulation and in impaired glucose homeostasis. In addition, emerging data on new onset DM in previously infected with SARS-CoV-2 patients, reinforce the hypothesis of a direct effect of SARS-CoV-2 on glucose metabolism. Attempting to find the culprit, we currently know that the pancreas and the endothelium have been found to express Angiotensin-converting enzyme 2 (ACE2) receptors, the main binding site of the virus. To move from bench to bedside, understanding the effects of COVID-19 on metabolism and glucose homeostasis is crucial to prevent and manage complications related to COVID-19 and support recovering patients. In this article we review the potential underlying pathophysiological mechanisms between COVID-19 and glucose dysregulation as well as the effects of antidiabetic treatment in patients with diabetes and COVID-19.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

